-
Catalog
C000079
-
Alternative name
Versican core protein CLIA KIT; Chondroitin sulfate proteoglycan core protein 2 CLIA KIT; Chondroitin sulfate proteoglycan 2 CLIA KIT; Glial hyaluronate-binding protein CLIA KIT; GHAP CLIA KIT; Large fibroblast proteoglycan CLIA KIT; PG-MVCAN CLIA KIT; CSPG2 CLIA KIT; Chondroitin sulfate proteoglycan 2 CLIA KIT; GHAP CLIA KIT
-
GeneVS
-
Species ReactivityHuman
-
SpecificityThis assay has high sensitivity and excellent specificity for detection of Versican (VS).
No significant cross-reactivity or interference between Versican (VS) and analogues was observed.
-
SamplesSerum, plasma and other biological fluids
-
Detection Range27.43-20000pg/mL
-
SensitivityThe minimum detectable dose of this kit is typically less than 12.59pg/mL.
-
PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Versican (VS) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Versican (VS) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
-
Product Description specificalPrinciple of the Assay: The microtiter plate provided in this kit has been pre-coated with an antigen. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated secondary antibody. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Versican (VS) level in the sample or standard.
-